|
GTF2H4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
3.66700000000719E-05 |
| Normal-vs-Stage3 |
1.62614366416847E-12 |
| Normal-vs-Stage4 |
4.99369989803711E-10 |
| Stage1-vs-Stage2 |
1.482630E-01 |
| Stage1-vs-Stage3 |
9.962600E-01 |
| Stage1-vs-Stage4 |
5.931400E-01 |
| Stage2-vs-Stage3 |
1.827650E-01 |
| Stage2-vs-Stage4 |
1.275440E-01 |
| Stage3-vs-Stage4 |
6.217200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
3.0260000061233E-09 |
| Normal-vs-Asian |
2.92843527205378E-12 |
| Caucasian-vs-AfricanAmerican |
9.059000E-01 |
| Caucasian-vs-Asian |
8.548600E-01 |
| AfricanAmerican-vs-Asian |
8.240400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
3.822600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
3.76698672255316E-12 |
| Normal-vs-Age(81-100Yrs) |
1.918240E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.743800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.340200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.215800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.599200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.284400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.550200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.808410E-01 |
| Classical-VS-Follicular |
2.49560000442628E-08 |
| Classical-VS-Other |
9.204200E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
7.102100E-03 |
| Tall-VS-Other |
4.411000E-01 |
| Tall-VS-Normal |
1.10530000041464E-07 |
| Follicular-VS-Other |
6.273500E-02 |
| Follicular-VS-Normal |
1.663050E-03 |
| Other-VS-Normal |
2.040400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62447832963153E-12 |
| Normal-vs-N1 |
9.20250542435497E-11 |
| N0-vs-N1 |
1.104780E-01 |
|
|
